JB Pharma has been hit with a ₹80.81 lakh GST penalty, raising questions about tax compliance in the pharma industry. What led to this action, and should investors be concerned? Here’s a complete breakdown of the case and its implications.
Glenmark Pharmaceuticals made headlines by appointing Kamlesh Gupta as its new Business Head. A move that is already generating considerable buzz across industry circles, LinkedIn networks, and healthcare news portals.
Read MoreRising tensions in the Middle East are threatening Indian pharmaceutical exports worth up to ₹5,000 crore. Shipping disruptions, rising freight costs, and unstable maritime routes could impact medicine supply to Gulf countries. The situation highlights the vulnerability of global pharma supply chains and the importance of stable trade routes.
Read More
